The primary objective of the study is to demonstrate that in pregnant women at high risk for preeclampsia from first-trimester multiparametric screening, the incidence of preterm PE after discontinuation of ASA at 24-28 weeks of gestation is non-inferior to that of the control group, who continue ASA until 36 weeks.
